American Drug Delivery & Formulation Summit 2025: Catalent's Expertise and Innovative Approach

The American Drug Delivery & Formulation Summit is a two-day event in Boston, MA, on September 15-16th, 2025, where industry leaders, experts, and specialists will discuss cutting-edge developments in pharmaceuticals, biologics, and delivery devices. Catalent, a leading contract development and manufacturing organization, will be present at booth #23, offering expert advice and innovative approaches to early-phase development.

The American Drug Delivery & Formulation Summit, scheduled for September 15-16, 2025, in Boston, MA, promises to be a pivotal event for the pharmaceutical industry. This two-day event will gather industry leaders, experts, and specialists to discuss the latest advancements in pharmaceuticals, biologics, and delivery devices. Catalent, a leading contract development and manufacturing organization, will be present at booth #23, offering expert advice and innovative approaches to early-phase development.

The summit will feature presentations and discussions on systemic and local delivery strategies, blood-brain barrier targeting, RMT modulation, and emerging modalities from companies such as Biogen, Sanofi, Merck, UCB, Eli Lilly, Alnylam, and Voyager. These sessions will provide actionable insights into tackling the unique challenges of gaining access to the brain and accelerating CNS therapy development [1].

The event will also delve into the latest advancements in advanced drug delivery systems (ADDS), which are specialized technologies designed to modify the release, absorption, distribution, and elimination of therapeutic agents. ADDS utilize various carriers such as nanoparticles, monoclonal antibodies, liposomes, and polymeric nanoparticles to enhance therapeutic outcomes while minimizing adverse effects. These systems have revolutionized treatment approaches across various therapeutic fields, including oncology, cardiology, neurology, and infectious diseases [2].

Catalent's presence at the summit underscores its commitment to driving innovation in drug delivery and formulation. The company's GPEx® Lightning Cell Line Development Technology and New Developability Assessment & Formulation Development Services will be featured at the event, providing attendees with insights into how these technologies can accelerate the path to patients [4].

The summit will also address the latest market trends and developments in ADDS. Nanoparticles and monoclonal antibodies are primarily shaping the parenteral administration of ADDS, while technological advancements continue to support neurological applications. The market for ADDS is expected to grow significantly, with the global market size projected to reach $102.2 billion by 2030, driven by the increasing demand for targeted and personalized therapies [2].

In conclusion, the American Drug Delivery & Formulation Summit will be a crucial event for investors and financial professionals looking to stay informed about the latest innovations and trends in drug delivery. With Catalent's expertise and the insights from leading industry experts, the summit promises to be a valuable platform for discussing the future of pharmaceuticals and biologics.

References:
[1] CNS Drug Delivery Summit. Retrieved from https://cns-drug-delivery.com/
[2] Advanced Drug Delivery Systems (ADDS) World Market Report 2025. Retrieved from https://www.globenewswire.com/news-release/2025/08/22/3137704/28124/en/Advanced-Drug-Delivery-Systems-ADDS-World-Market-Report-2025-Nanoparticles-and-mAbs-Primarily-Shaping-Parenteral-Administration-of-ADDS.html
[4] Catalent at BioProcess International (BPI) East 2025. Retrieved from https://www.catalent.com/events/bpi-east-2025/